Steroids and Immunosuppressants: Oral Health Effects

Topic: Oral health effects of systemic steroids, inhaled steroids, biologics, DMARDs, and transplant immunosuppressants

German terms: Immunsuppression, Kortikosteroide, immunsupprimierte Patientinnen und Patienten, opportunistische Infektionen

Common drug groups: systemic corticosteroids, inhaled corticosteroids, methotrexate, biologic DMARDs, JAK inhibitors, tacrolimus, cyclosporine, mycophenolate, azathioprine, sirolimus, and post-transplant regimens.

Dental role: Identify infection risk, oral candidiasis, delayed healing, atypical oral lesions, periodontal risk, drug-related oral changes, and situations requiring medical coordination before invasive dental treatment.

This article is for dental education only. A dentist should not stop, reduce, or delay steroids, biologics, transplant drugs, or DMARDs independently. Immunosuppressive medication changes must be coordinated with the prescribing physician. The dental priority is careful history-taking, infection screening, prevention, safe timing of invasive procedures, and urgent referral when spreading infection or systemic illness is present.

Steroids and immunosuppressants can protect patients from inflammatory, autoimmune, transplant, and respiratory disease complications, but they can also change oral disease patterns. The mouth may show more candidiasis, recurrent infections, delayed healing, gingival changes, xerostomia-related caries, or atypical ulceration.

The dental risk depends on drug type, dose, duration, combination therapy, diabetes, age, oral hygiene, smoking, neutrophil count, transplant status, and whether the procedure is simple or invasive.

The key clinical principle is: immunosuppression does not automatically mean no dental treatment, but it does mean better planning. Diagnose early, control infection, use minimally traumatic care, and coordinate with the physician when risk is high.

• Most important dental concern: oral infection may progress faster or present atypically.
• Common oral findings: candidiasis, recurrent herpes, delayed healing, mucosal ulceration, periodontal deterioration, and caries related to dry mouth.
• Highest-risk situations: transplant patients, biologic or multiple immunosuppressive therapy, high-dose systemic steroids, neutropenia, poorly controlled diabetes, and active infection.
• First dental response: detailed medication history, infection screening, oral hygiene optimization, and targeted prevention.
• Medical coordination: required for major surgery, severe immunosuppression, unclear blood counts, transplant status, or uncontrolled systemic disease.

• Systemic corticosteroids: prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone.
• Inhaled corticosteroids: beclomethasone, budesonide, fluticasone, mometasone; associated with oral candidiasis risk if mouth rinsing and inhaler technique are poor.
• Conventional DMARDs: methotrexate, azathioprine, leflunomide, mycophenolate; may increase infection or mucosal adverse-effect concerns in selected patients.
• Biologic DMARDs: TNF inhibitors, IL inhibitors, B-cell therapies; infection risk and surgical timing may need physician coordination.
• JAK inhibitors: targeted immunomodulators with infection-risk considerations.
• Transplant immunosuppressants: tacrolimus, cyclosporine, mycophenolate, sirolimus, corticosteroids, and combination regimens.
• Gingival overgrowth risk: cyclosporine can contribute, especially when combined with calcium channel blockers.
• Important: medication benefit may be life-saving; dental decisions must not destabilize systemic disease.

• Oral candidiasis: white plaques, erythematous patches, angular cheilitis, denture stomatitis, burning, altered taste, or soreness.
• Recurrent viral lesions: herpes simplex may recur more often or heal more slowly in susceptible patients.
• Delayed healing: may occur after extraction, surgery, ulcers, trauma, or denture irritation.
• Periodontal deterioration: chronic steroid use and immunosuppression may be associated with periodontal concerns, especially when plaque control is poor.
• Opportunistic infection: mild-looking lesions can become clinically significant in severely immunosuppressed patients.
• Drug-related gingival enlargement: especially with cyclosporine, sometimes worsened by plaque inflammation and calcium channel blockers.
• Xerostomia and caries risk: some regimens and comorbidities can contribute to dry mouth and higher caries risk.
• Atypical symptoms: infection may present with less obvious redness or swelling in some immunosuppressed patients.

Inhaled corticosteroids can increase the risk of oropharyngeal candidiasis, especially when high doses, poor inhaler technique, dry mouth, dentures, or poor oral hygiene are present.

• Ask about inhaler type, dose, frequency, spacer use, and whether the patient rinses after use.
• Advise the patient to rinse the mouth with water and spit after using an inhaled corticosteroid.
• Check for candidiasis if the patient reports burning, soreness, taste change, or removable white plaques.
• Assess denture hygiene and night-time denture removal when relevant.
• Do not tell the patient to stop asthma or COPD medication; coordinate with the physician if needed.

Many routine dental procedures may be possible, but invasive care needs risk assessment. The question is not only “Is the patient immunosuppressed?” but “How immunosuppressed, why, and what procedure is planned?”

• Confirm diagnosis, drugs, dose, duration, and last dose or infusion schedule when relevant.
• Ask about transplant history, biologic therapy, chemotherapy, neutropenia, recurrent infections, diabetes, and recent hospitalizations.
• Consider recent blood counts when the patient is severely immunosuppressed or has hematologic disease.
• Control acute oral infection before elective invasive care when possible.
• Use minimally traumatic technique, good hemostasis, and close postoperative follow-up.
• Medical consultation is appropriate for transplant patients, severe immunosuppression, unclear immune status, major surgery, or active systemic infection.
• Antibiotic prophylaxis is not automatic for all immunosuppressed patients; it should be individualized according to medical condition, procedure, and current guidance.

Short courses of steroids are commonly used in dentistry for selected inflammatory indications, but long-term or high-dose systemic steroid exposure can affect host response, infection risk, glucose control, and tissue repair.

• Check whether the patient uses daily systemic steroids or repeated steroid courses.
• Ask about diabetes, gastric ulcer disease, hypertension, infection history, osteoporosis, and adrenal suppression risk.
• Do not prescribe steroids to “calm swelling” when the swelling is caused by untreated infection without source control.
• Monitor healing closely after extraction or surgery in patients with high-risk steroid exposure.

• Current or recent transplant immunosuppression
• High-dose systemic corticosteroids or multiple immunosuppressants
• Biologic DMARD or JAK inhibitor therapy with planned surgical extraction or implant procedure
• History of recurrent infections or delayed wound healing
• Poorly controlled diabetes or severe xerostomia
• Suspected neutropenia or abnormal blood counts
• Active oral candidiasis, herpes, ulceration, abscess, or spreading odontogenic infection
• Unexplained oral ulcer lasting more than two weeks
• Fever, malaise, lymphadenopathy, trismus, dysphagia, or facial swelling
• Invasive dental treatment when immune status is unclear

The biggest mistake is assuming the mouth looks “not too bad” because the inflammatory response is muted. In an immunosuppressed patient, a small ulcer, mild swelling, candidiasis, or delayed socket healing can represent a larger clinical problem. Look for systemic signs, medication intensity, and progression over time.

• Take a precise medication history: drug name, dose, route, frequency, duration, indication, and prescriber.
• Screen for oral infection: candidiasis, herpes, abscess, periodontal infection, peri-implant infection, and non-healing ulcers.
• Reduce microbial burden: plaque control, periodontal maintenance, denture hygiene, caries control, and fluoride support.
• Plan invasive care carefully: timing, extent, blood tests if needed, physician consultation, and close review.
• Avoid unnecessary steroids: especially when active infection is not controlled.
• Treat candidiasis appropriately: identify risk factors and use antifungal therapy when diagnosis supports it.
• Document clearly: immunosuppression status, consultation advice, consent, and postoperative instructions.
• Recall more frequently when risk is high: prevention and early diagnosis are safer than late emergency care.

• Tell the dentist about all steroid, biologic, transplant, and immune-system medications.
• Do not stop immunosuppressive medication without the prescribing physician.
• Rinse the mouth with water and spit after using an inhaled corticosteroid.
• Clean dentures daily and leave them out at night when possible.
• Report white patches, burning, ulcers, delayed healing, swelling, pus, fever, or recurrent cold sores.
• Keep excellent brushing and interdental cleaning habits because plaque-related infection is more risky.
• Attend regular dental recalls and periodontal maintenance appointments.
• Use fluoride toothpaste and additional fluoride support if dry mouth or high caries risk is present.
• Contact the dental clinic early if a socket, ulcer, or surgical site is not healing normally.

For immunosuppressed patients, prevention is treatment. Removing dental infection sources early, controlling plaque, managing dentures, preventing caries, and reviewing suspicious lesions can prevent emergency complications later.

• Facial, submandibular, sublingual, or neck swelling
• Fever, malaise, tachycardia, dehydration, or systemic illness
• Trismus, dysphagia, drooling, voice change, or breathing difficulty
• Rapidly progressive odontogenic infection
• Post-extraction socket with worsening pain, swelling, pus, or delayed healing
• Oral ulcer that persists beyond two weeks or appears atypical
• Extensive candidiasis not responding to routine treatment
• Recurrent or severe herpes lesions in an immunosuppressed patient
• Bleeding, bruising, or infection signs with abnormal blood counts
• Any dental infection in a transplant patient with fever or systemic symptoms

• Systemic Corticosteroids
• Inhaled Corticosteroids
• Cyclosporine and Gingival Overgrowth
• Tacrolimus and Transplant Dentistry
• Methotrexate and Oral Ulcers
• Biologic DMARDs
• Oral Candidiasis
• Herpes Simplex Virus
• Dental Infection Risk
• Medical Consultation Before Dental Surgery

Steroids and immunosuppressants can increase oral infection risk, candidiasis risk, delayed healing, periodontal vulnerability, drug-related gingival changes, and atypical lesion presentation. Dental management begins with a precise medication history, recognition of risk level, prevention, plaque control, denture hygiene, fluoride support, and early treatment of oral infection. Inhaled steroid users should rinse and spit after inhaler use to reduce candidiasis risk. Transplant patients, patients on biologics or multiple immunosuppressants, high-dose systemic steroid users, patients with abnormal blood counts, and patients needing invasive procedures may require physician coordination. Antibiotic prophylaxis is not automatic for all immunosuppressed patients; it should be individualized. Dentists should never stop immunosuppressive drugs independently and should not use steroids to mask untreated infection. Any spreading infection, fever, delayed healing, persistent ulcer, or severe candidiasis requires prompt escalation.